KATHLEEN BRESLIN: Open Payments
NPI 1801265202 · BERKELEY HEIGHTS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 25 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $17 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $211 |
| Corcept Therapeutics | 6 | $121 |
| Insulet Corporation | 3 | $66 |
| Abbott Laboratories | 3 | $65 |
| Amgen Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $35 |
| Radius Health, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: Ozempic, Korlym, Omnipod, FREESTYLE LIBRE 3, Rybelsus, EVENITY, MOUNJARO, Tymlos.
Industry payments across NJ — which companies pay providers there.
